Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Comparison of CRISPR and marker-based methods for the engineering of phage T7

  • Grigonyte, Aurelija M.
  • Harrison, Christian
  • MacDonald, Paul R.
  • Montero-Blay, Ariadna, 1994-
  • Tridgett, Matthew
  • Duncan, John S.
  • Sagona, Antonia P.
  • Constantinidou, Chrystala
  • Jaramillo, Alfonso
  • Millard, Andrew
With the recent rise in interest in using lytic bacteriophages as therapeutic agents, there is an urgent requirement to understand their fundamental biology to enable the engineering of their genomes. Current methods of phage engineering rely on homologous recombination, followed by a system of selection to identify recombinant phages. For bacteriophage T7, the host genes cmk or trxA have been used as a selection mechanism along with both type I and II CRISPR systems to select against wild-type phage and enrich for the desired mutant. Here, we systematically compare all three systems; we show that the use of marker-based selection is the most efficient method and we use this to generate multiple T7 tail fibre mutants. Furthermore, we found the type II CRISPR-Cas system is easier to use and generally more efficient than a type I system in the engineering of phage T7. These results provide a foundation for the future, more efficient engineering of bacteriophage T7., A.M.G. is funded by a doctoral fellowship from the EPSRC & BBSRC Centre for Doctoral Training in Synthetic Biology (grant EP/L016494/1). P.R.M is funded by a doctoral fellowship from the EPSRC Doctoral Training Centre Molecular Organisation and Assembly in Cells (Grant No. EP/F500378/1). C.H. is funded by a PhD scholarship from the Dept Genetics and Genome Biology, University of Leicester. A.M.B, A.P.S. were funded by the European Commission grant (FP7-ICT-610730, EVOPROG) to A.J. J.D. was funded by the European Commission grant (FP7-KBBE-613745, PROMYS) to A.J. A.J. is funded by the European Commission grants (FP7-ICT-610730, EVOPROG; FP7-KBBE-613745, PROMYS; H2020-MSC-642738, MetaRNA), the BBSRC grant EVO-ENGINE BB/P020615/1, FP7-KBBE (no 613745, PROMYS), and EPSRC-BBSRC (BB/M017982/1, WISB center). A.M. is funded by MRC (MR/L015080/1) and NERC (NE/N019881/1)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Model-based design of RNA hybridization networks implemented in living cells

  • Rodrigo, Guillermo
  • Prakash, Satya
  • Shen, Shensi
  • Majer, Eszter
  • Jaramillo, Alfonso
  • Daròs, José-Antonio|||0000-0002-6535-2889
[EN] Synthetic gene circuits allow the behavior of living cells to be reprogrammed, and non-coding small RNAs (sRNAs) are increasingly being used as programmable regulators of gene expression. However, sRNAs (natural or synthetic) are generally used to regulate single target genes, while complex dynamic behaviors would require networks of sRNAs regulating each other. Here, we report a strategy for implementing such networks that exploits hybridization reactions carried out exclusively by multifaceted sRNAs that are both targets of and triggers for other sRNAs. These networks are ultimately coupled to the control of gene expression. We relied on a thermo-dynamic model of the different stable conformational states underlying this system at the nucleotide level. To test our model, we designed five different RNA hybridization networks with a linear architecture, and we implemented them in Escherichia coli. We validated the network architecture at the molecular level by native polyacrylamide gel electrophoresis, as well as the network function at the bacterial population and single-cell levels with a fluorescent reporter. Our results suggest that it is possible to engineer complex cellular programs based on RNA from first principles. Because these networks are mainly based on physical interactions, our designs could be expanded to other organisms as portable regulatory resources or to implement biological computations., The Consejo Superior de Investigaciones Cientificas (CSIC) Intramural [grant number 201440I017]; the Ministerio de Economia, Industria y Competitividad (MINECO)/FEDER [grant number BFU2015-66894-P]; and the AXA Research Fund Postdoctoral fellowship to G.R. The predoctoral fellowship [grant number AP2012-3751, MECD] to E.M. The Ministerio de Economia, Industria y Competitividad (MINECO) [grant numbers BIO2014-54269-R, AGL2013-49919-EXP] to J.A.D. The 7th Framework Programme [grant numbers 610730 (EVO-PROG), 613745 (PROMYS)]; the Horizon 2020 Marie Sklodowska-Curie [grant number 642738 (MetaRNA)]; the Engineering and Physical Sciences Research Council (EPSRC) and the Biotechnology and Biological Sciences Research Council (BBSRC) [grant number BB/M017982/1 (WISB centre)]; and the School of Life Sciences (U. Warwick) [startup allocation] to A.J. Funding for open access charge: EPSRC/BBSRC [BB/M017982/1 to A.J.].
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Engineering of biomolecules by bacteriophage directed evolution

  • Brödel, Andreas K.
  • Isalan, Mark
  • Jaramillo, Alfonso
Conventional in vivo directed evolution methods have primarily linked the biomolecule's activity to bacterial cell growth. Recent developments instead rely on the conditional growth of bacteriophages (phages), viruses that infect and replicate within bacteria. Here we review recent phage-based selection systems for in vivo directed evolution. These approaches have been applied to evolve a wide range of proteins including transcription factors, polymerases, proteases, DNA-binding proteins, and protein–protein interactions. Advances in this field expand the possible applications of protein and RNA engineering. This will ultimately result in new biomolecules with tailor-made properties, as well as giving us a better understanding of basic evolutionary processes., AB, AJ and MI were supported by the European Commission grant FP7-ICT-2013-10 (no. 610730, EVOPROG) and the BBSRC grant EVO-ENGINE BB/P020615/1. AJ is funded by FP7-KBBE (no. 613745, PROMYS), H2020 Marie Sklodowska-Curie (no. 642738, MetaRNA) and EPSRC-BBSRC (no. BB/M017982/1, WISB center). MI is funded by New Investigator award no. WT102944 from the Wellcome Trust U.K., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Engineering CRISPR guide RNA riboswitches for in vivo applications

  • Galizi, Roberto
  • Jaramillo, Alfonso
CRISPR-based genome editing provides a simple and scalable toolbox for a variety of therapeutic and biotechnology applications. Whilst the fundamental properties of CRISPR proved easily transferable from the native prokaryotic hosts to eukaryotic and multicellular organisms, the tight control of the CRISPR-editing activity remains a major challenge. Here we summarise recent developments of CRISPR and riboswitch technologies and recommend novel functionalised synthetic-gRNA (sgRNA) designs to achieve inducible and spatiotemporal regulation of CRISPR-based genetic editors in response to cellular or extracellular stimuli. We believe that future advances of these tools will have major implications for both basic and applied research, spanning from fundamental genetic studies and synthetic biology to genetic editing and gene therapy., This work was supported by grants from the European Commission FP7-ICT-FET-610730 (EVOPROG), FP7-KBBE-613745 (PROMYS), H2020 Marie Sklodowska-Curie 642,738 (MetaRNA), EPSRC-BBSRC BB/M017982/1 (WISB center), BBSRC grant EVO-ENGINE BB/P020615/1 and the startup allocation from the School of Life Sciences., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Accelerated evolution of a minimal 63–amino acid dual transcription factor

  • Brödel, Andreas K.
  • Rodrigues, Rui
  • Jaramillo, Alfonso
  • Isalan, Mark
Transcription factors control gene expression in all life. This raises the question of what is the smallest protein that can support such activity. In nature, Cro from bacteriophage λ is one of the smallest known repressors (66 amino acids), and activators are typically much larger (e.g., λ cI, 237 amino acids). Previous efforts to engineer a minimal activator from λ Cro resulted in no activity in vivo in cells. In this study, we show that directed evolution results in a new Cro activator-repressor that functions as efficiently as λ cI in vivo. To achieve this, we develop phagemid-assisted continuous evolution (PACEmid). We find that a peptide as small as 63 amino acids functions efficiently as an activator and/or repressor. To our knowledge, this is the smallest protein activator that enables polymerase recruitment, highlighting the capacity of transcription factors to evolve from very short peptide sequences., This research was supported by the European Commission grant FP7-ICT-2013-10 (no. 610730, EVOPROG) and the BBSRC grant EVO-ENGINE BB/P020615/1. A.J. is funded by FP7-KBBE (no. 613745, PROMYS), H2020 Marie Sklodowska-Curie (no. 642738, MetaRNA), and EPSRC-BBSRC (no. BB/M017982/1, WISB center). M.I. is funded by New Investigator award no WT102944 from the Wellcome Trust U.K and by the Volkswagen Foundation., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Comparison of CRISPR and marker-based methods for the engineering of phage T7

  • Grigonyte, Aurelija M.
  • Harrison, Christian
  • MacDonald, Paul R.
  • Montero-Blay, Ariadna
  • Tridgett, Matthew
  • Duncan, John
  • Sagona, Antonia P.
  • Constantinidou, Chrystala
  • Jaramillo, Alfonso
  • Millard, Andrew
This article belongs to the Section Bacterial Viruses., With the recent rise in interest in using lytic bacteriophages as therapeutic agents, there is an urgent requirement to understand their fundamental biology to enable the engineering of their genomes. Current methods of phage engineering rely on homologous recombination, followed by a system of selection to identify recombinant phages. For bacteriophage T7, the host genes cmk or trxA have been used as a selection mechanism along with both type I and II CRISPR systems to select against wild-type phage and enrich for the desired mutant. Here, we systematically compare all three systems; we show that the use of marker-based selection is the most efficient method and we use this to generate multiple T7 tail fibre mutants. Furthermore, we found the type II CRISPR-Cas system is easier to use and generally more efficient than a type I system in the engineering of phage T7. These results provide a foundation for the future, more efficient engineering of bacteriophage T7., A.M.G. is funded by a doctoral fellowship from the EPSRC & BBSRC Centre for Doctoral Training in Synthetic Biology (grant EP/L016494/1). P.R.M is funded by a doctoral fellowship from the EPSRC Doctoral Training Centre Molecular Organisation and Assembly in Cells (Grant No. EP/F500378/1). C.H. is funded by a PhD scholarship from the Dept Genetics and Genome Biology, University of Leicester. A.M.B, A.P.S. were funded by the European Commission grant (FP7-ICT-610730, EVOPROG) to A.J. J.D. was funded by the European Commission grant (FP7-KBBE-613745, PROMYS) to A.J. A.J. is funded by the European Commission grants (FP7-ICT-610730, EVOPROG; FP7-KBBE-613745, PROMYS; H2020-MSC-642738, MetaRNA), the BBSRC grant EVO-ENGINE BB/P020615/1, FP7-KBBE (no 613745, PROMYS), and EPSRC-BBSRC (BB/M017982/1, WISB center). A.M. is funded by MRC (MR/L015080/1) and NERC (NE/N019881/1)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Engineering of a promoter repressed by a light-regulated transcription factor in Escherichia coli

  • Camsund, Daniel
  • Jaramillo, Alfonso
  • Lindblad, Peter
Light-regulated gene expression systems allow controlling gene expression in space and time with high accuracy. Contrary to previous synthetic light sensors that incorporate two-component systems which require localization at the plasma membrane, soluble one-component repression systems provide several advantageous characteristics. Firstly, they are soluble and able to diffuse across the cytoplasm. Secondly, they are smaller and of lower complexity, enabling less taxing expression and optimization of fewer parts. Thirdly, repression through steric hindrance is a widespread regulation mechanism that does not require specific interaction with host factors, potentially enabling implementation in different organisms. Herein, we present the design of the synthetic promoter PEL that in combination with the light-regulated dimer EL222 constitutes a one-component repression system. Inspired by previously engineered synthetic promoters and the Escherichia coli lacZYA promoter, we designed PEL with two EL222 operators positioned to hinder RNA polymerase binding when EL222 is bound. PEL is repressed by EL222 under conditions of white light with a light-regulated repression ratio of five. Further, alternating conditions of darkness and light in cycles as short as one hour showed that repression is reversible. The design of the PEL-EL222 system herein presented could aid the design and implementation of analogous one-component optogenetic repression systems. Finally, we compare the PEL-EL222 system with similar systems and suggest general improvements that could optimize and extend the functionality of EL222-based as well as other one-component repression systems., AJ acknowledges funding from FP7-ICT-610730 (EVOPROG), FP7-KBBE-613745 (PROMYS), H2020 Marie Sklodowska-Curie Actions 642738 (MetaRNA), Biotechnology and Biological Sciences Research Council (BBSRC) BB/P020615/1 (EVO-ENGINE), Engineering and Physical Sciences Research Council-Biotechnology and Biological Sciences Research Council (EPSRC-BBSRC) BB/M017982/1 (WISB centre), and the departmental allocation from the School of Life Sciences (U. Warwick). PL acknowledges funding from the Knut och Alice Wallenbergs Stiftelse (project MoSE, No. 2011.0067) and the Swedish Energy Agency (No. 11674-5)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Intracellular directed evolution of proteins from combinatorial libraries based on conditional phage replication

  • Brödel, Andreas K.
  • Jaramillo, Alfonso
  • Isalan, Mark
Directed evolution is a powerful tool to improve the characteristics of biomolecules. Here we present a protocol for the intracellular evolution of proteins with distinct differences and advantages in comparison with established techniques. These include the ability to select for a particular function from a library of protein variants inside cells, minimizing undesired coevolution and propagation of nonfunctional library members, as well as allowing positive and negative selection logics using basally active promoters. A typical evolution experiment comprises the following stages: (i) preparation of a combinatorial M13 phagemid (PM) library expressing variants of the gene of interest (GOI) and preparation of the Escherichia coli host cells; (ii) multiple rounds of an intracellular selection process toward a desired activity; and (iii) the characterization of the evolved target proteins. The system has been developed for the selection of new orthogonal transcription factors (TFs) but is capable of evolving any gene—or gene circuit function—that can be linked to conditional M13 phage replication. Here we demonstrate our approach using as an example the directed evolution of the bacteriophage λ cI TF against two synthetic bidirectional promoters. The evolved TF variants enable simultaneous activation and repression against their engineered promoters and do not cross-react with the wild-type promoter, thus ensuring orthogonality. This protocol requires no special equipment, allowing synthetic biologists and general users to evolve improved biomolecules within ∼7 weeks., This research was supported by European Commission grant FP7-ICT-2013-10 (No. 610730, EVOPROG). A.J. was funded by FP7-KBBE (Nos. 613745, PROMYS), H2020 Marie Sklodowska-Curie (No. 642738, MetaRNA) and EPSRC-BBSRC (No. BB/M017982/1, WISB center). M.I. is funded by New Investigator award no. WT102944 from the Wellcome Trust UK., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

T7 phage-assisted evolution of riboswitches using error-prone replication and dual selection

  • Goicoechea Serrano, Eduardo
  • Blázquez-Bondia, Carlos
  • Jaramillo, Alfonso
Leveraging riboswitches, non-coding mRNA fragments pivotal to gene regulation, poses a challenge in effectively selecting and enriching these functional genetic sensors, which can toggle between ON and OFF states in response to their cognate inducers. Here, we show our engineered phage T7, enabling the evolution of a theophylline riboswitch. We have replaced T7's DNA polymerase with a transcription factor controlled by a theophylline riboswitch and have created two types of host environments to propagate the engineered phage. Both types host an error-prone T7 DNA polymerase regulated by a T7 promoter along with another critical gene-either cmk or pifA, depending on the host type. The cmk gene is necessary for T7 replication and is used in the first host type for selection in the riboswitch's ON state. Conversely, the second host type incorporates the pifA gene, leading to abortive T7 infections and used for selection in the riboswitch's OFF state. This dual-selection system, termed T7AE, was then applied to a library of 65,536 engineered T7 phages, each carrying randomized riboswitch variants. Through successive passage in both host types with and without theophylline, we observed an enrichment of phages encoding functional riboswitches that conferred a fitness advantage to the phage in both hosts. The T7AE technique thereby opens new pathways for the evolution and advancement of gene switches, including non-coding RNA-based switches, setting the stage for significant strides in synthetic biology., EG was supported by a Marie Sklodowska-Curie early training fellowship. This work was supported by the European Union’s Horizon 2020 research and innovation programme under ITN Marie Sklodowska-Curie (grant agreement 642738 [MetaRNA]), the Biotechnology and Biological Sciences Research Council (grant BB/P020615/1 [EVO- ENGINE], grant BB/M017982/1 [WISB]), the Spanish Ministerio de Ciencia e Innovación (grant PID2020-118436GB-I00 [GeneCircuits+ +]) and the European Innovation Council (grant 101070948 [PhotoSynH2]) to AJ., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Comparison of CRISPR and marker-based methods for the engineering of phage T7

  • Grigonyte, Aurelija M.
  • Harrison, Christian
  • MacDonald, Paul R.
  • Montero-Blay, Ariadna, 1994-
  • Tridgett, Matthew
  • Duncan, John S.
  • Sagona, Antonia P.
  • Constantinidou, Chrystala
  • Jaramillo, Alfonso
  • Millard, Andrew
With the recent rise in interest in using lytic bacteriophages as therapeutic agents, there is an urgent requirement to understand their fundamental biology to enable the engineering of their genomes. Current methods of phage engineering rely on homologous recombination, followed by a system of selection to identify recombinant phages. For bacteriophage T7, the host genes cmk or trxA have been used as a selection mechanism along with both type I and II CRISPR systems to select against wild-type phage and enrich for the desired mutant. Here, we systematically compare all three systems; we show that the use of marker-based selection is the most efficient method and we use this to generate multiple T7 tail fibre mutants. Furthermore, we found the type II CRISPR-Cas system is easier to use and generally more efficient than a type I system in the engineering of phage T7. These results provide a foundation for the future, more efficient engineering of bacteriophage T7., A.M.G. is funded by a doctoral fellowship from the EPSRC & BBSRC Centre for Doctoral Training in Synthetic Biology (grant EP/L016494/1). P.R.M is funded by a doctoral fellowship from the EPSRC Doctoral Training Centre Molecular Organisation and Assembly in Cells (Grant No. EP/F500378/1). C.H. is funded by a PhD scholarship from the Dept Genetics and Genome Biology, University of Leicester. A.M.B, A.P.S. were funded by the European Commission grant (FP7-ICT-610730, EVOPROG) to A.J. J.D. was funded by the European Commission grant (FP7-KBBE-613745, PROMYS) to A.J. A.J. is funded by the European Commission grants (FP7-ICT-610730, EVOPROG; FP7-KBBE-613745, PROMYS; H2020-MSC-642738, MetaRNA), the BBSRC grant EVO-ENGINE BB/P020615/1, FP7-KBBE (no 613745, PROMYS), and EPSRC-BBSRC (BB/M017982/1, WISB center). A.M. is funded by MRC (MR/L015080/1) and NERC (NE/N019881/1)